NKT Therapeutics, Inc. Obtains $8,000,000 Series A Financing Round

  • Feed Type
  • Date
    3/16/2009
  • Company Name
    NKT Therapeutics, Inc.
  • Mailing Address
    233 Needham Street Newton, MA 02464
  • Company Description
    NKT Therapeutics, Inc. (the Company) is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease.
  • Website
    http://www.nktrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    MedImmune Ventures

By posting a comment, you agree to our terms and conditions.